Abstract
Objective
The role of the melanocortin system in the feeding effects of peripheral peptide YY(3-36) (PYY(3-36)) and ghrelin was investigated using the agouti (A(y)/a) mouse as a model of abnormal melanocortin signalling. Furthermore, we examined whether the ectopic expression of agouti protein in A(y)/a mice results in complete MC4-R inhibition, by studying the effects of peripheral alpha-melanocyte-stimulating hormone (alpha-MSH) and leptin on food intake.Design
Adult A(y)/a mice were studied in the pre-obese state (7-8 weeks) and obese state (14-15 weeks). Animals received PYY(3-36) (0.02 micromol/kg), NDP-alpha-MSH (0.2 micromol/kg), leptin (2 micromol/kg) (all 24 h fasted state) and ghrelin (0.2 micromol/kg) (fed state) by intraperitoneal (i.p.) injection. Age-matched A(y)/a controls received i.p. saline. A separate cohort of wild-type (WT), age-matched controls received the same peptide dose or saline. Food intake was measured at 1, 2, 4, 8 and 24 h post-injection and compared in all four groups. Plasma leptin-, ghrelin- and PYY-like immunoreactivity (IR) were measured using radioimmunoassay (RIA).Results
At 2 h post-injection, PYY(3-36) reduced food intake in pre-obese and obese A(y)/a mice, whereas ghrelin had no effect. Plasma ghrelin levels were significantly reduced in pre-obese and obese A(y)/a mice compared to WT controls. Peripheral administration of NDP-alpha-MSH and leptin acutely suppressed feeding (0-2 h) in pre-obese and obese A(y)/a mice.Conclusions
Responsiveness of pre-obese and obese A(y)/a mice to PYY(3-36) suggests that the melanocortin system may not be essential for the anorectic effects of this peptide. Melanocortinergic antagonism by agouti protein in A(y)/a mice may be sufficient to block the effects of endogenous, but not exogenous PYY(3-36), alpha-MSH and leptin. The mechanism underlying ghrelin resistance in A(y)/a mice may result from antagonism of hypothalamic melanocortin receptors-4 by agouti protein, supporting a role for the melanocortin system in mediating ghrelin's actions.Full text links
Read article at publisher's site: https://doi.org/10.1038/sj.ijo.0802646
Read article for free, from open access legal sources, via Unpaywall: https://www.nature.com/articles/0802646.pdf
References
Articles referenced by this article (43)
Physiological consequences of ectopic agouti gene expression: the yellow obese mouse syndrome.
Physiol Genomics, (3):151-163 1999
MED: 11015573
Ectopic expression of the agouti gene in transgenic mice causes obesity, features of type II diabetes, and yellow fur.
Proc Natl Acad Sci U S A, (11):4728-4732 1995
MED: 7761391
Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor.
Nature, (6500):799-802 1994
MED: 7935841
Targeted disruption of the melanocortin-4 receptor results in obesity in mice.
Cell, (1):131-141 1997
MED: 9019399
Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein.
Science, (5335):135-138 1997
MED: 9311920
The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice.
Proc Natl Acad Sci U S A, (25):15043-15048 1998
MED: 9844012
Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons.
Nat Neurosci, (4):271-272 1998
MED: 10195157
Positional cloning of the mouse obese gene and its human homologue.
Nature, (6505):425-432 1994
MED: 7984236
Show 10 more references (10 of 43)
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1038/sj.ijo.0802646
Article citations
High-Fat Diet Induces Resistance to Ghrelin and LEAP2 Peptide Analogs in Mice.
Physiol Res, 72(5):607-619, 01 Nov 2023
Cited by: 2 articles | PMID: 38015760 | PMCID: PMC10751049
Ghrelin cell-expressed insulin receptors mediate meal- and obesity-induced declines in plasma ghrelin.
JCI Insight, 6(18):e146983, 02 Sep 2021
Cited by: 10 articles | PMID: 34473648 | PMCID: PMC8492315
LEAP2 deletion in mice enhances ghrelin's actions as an orexigen and growth hormone secretagogue.
Mol Metab, 53:101327, 21 Aug 2021
Cited by: 31 articles | PMID: 34428557 | PMCID: PMC8452786
"A LEAP 2 conclusions? Targeting the ghrelin system to treat obesity and diabetes".
Mol Metab, 46:101128, 25 Nov 2020
Cited by: 21 articles | PMID: 33246141 | PMCID: PMC8085568
Review Free full text in Europe PMC
Acylated Ghrelin as a Multi-Targeted Therapy for Alzheimer's and Parkinson's Disease.
Front Neurosci, 14:614828, 14 Dec 2020
Cited by: 18 articles | PMID: 33381011 | PMCID: PMC7767977
Review Free full text in Europe PMC
Go to all (37) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Effects of peptide YY[3-36] on short-term food intake in mice are not affected by prevailing plasma ghrelin levels.
Endocrinology, 145(11):4967-4975, 29 Jul 2004
Cited by: 36 articles | PMID: 15284202
Inhibition of food intake in obese subjects by peptide YY3-36.
N Engl J Med, 349(10):941-948, 01 Sep 2003
Cited by: 856 articles | PMID: 12954742
Role of melanocortinergic neurons in feeding and the agouti obesity syndrome.
Nature, 385(6612):165-168, 01 Jan 1997
Cited by: 1131 articles | PMID: 8990120
Brain somatic cross-talk: ghrelin, leptin and ultimate challengers of obesity.
Nutr Neurosci, 8(1):1-5, 01 Feb 2005
Cited by: 25 articles | PMID: 15909762
Review